TM alfa inhibits thrombin generation and enhances pro-CPB2 activation in plasma.
TM alfa inactivates C5a by removal of the C-terminal arginine via CPB2.
TM alfa inhibits C5a-induced human neutrophil migration through CPB2.
TM alfa prolongs clot lysis time in a CPB2-dependent manner.